Teva Reports Encouraging Data From Late-Stage Schizophrenia Trial
Teva Reports Fourth Quarter and Full Year 2021 Financial Results | Business Wire
The Teva Pharmaceutical Industries Limited (NYSE:TEVA) Yearly Results Are Out And Analysts Have Published New Forecasts
Teva Reports Fourth Quarter and Full Year 2021 Financial Results | Business Wire
2021 Season Results: TEVA Corporation
Teva Pharmaceutical Industries Ltd (NYSE:TEVA) Delivered Strong Results In 2020 Thanks To Uninterrupted Demand For Essential Medicines During The Pandemic | StocksEarning.com
Teva Reports Second Quarter 2021 Financial Results | Business Wire
Teva Announces Results from Exploratory 52-Week Phase 2 PRIDE-HD Study of Pridopidine in Huntington Disease - Huntington's Disease News
Teva's new CEO Schultz to take post Wednesday | The Times of Israel
Teva Pharmaceutical Industries Limited 2021 Q3 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceuticals (@TevaUSA) / Twitter
Teva Reports Third Quarter 2020 Financial Results | Business Wire
Teva cuts forecast for 2017 amid competition to flagship Copaxone drug | The Times of Israel
After disappointing results, Teva announces plans to lay off thousands
Teva Reports Third Quarter 2021 Financial Results
Generic Versions Of Copaxone Take Toll On Teva 3Q Results - Drug Discovery and Development
Five Considerations After Teva Pharmaceuticals' Q3 Report (NYSE:TEVA) | Seeking Alpha
Can Teva Pharmaceutical's Q4 results bring positive surprise? - NewsBreak
Teva Reports Fourth Quarter and Full Year 2019 Financial Results | Business Wire
Teva to Cut 7,000 Jobs After Disappointing Quarter Results
Teva will report Wednesday the results of the fourth and final quarter of 2021 :: Israeli Financial News - The Israeli Economic World
Teva backs full-year guidance despite Q3 sales miss
Teva Pharmaceutical Industries Limited 2021 Q4 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical Industries Limited 2021 Q2 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
Can Teva Pharmaceutical's Q4 results bring positive surprise? | Seeking Alpha
Subcutaneous Cinqair results add to Teva's troubles
US: 44 States Sue Pharmaceutical Company Teva for Price Fixing | News | teleSUR English
Teva Pharmaceutical Industries Limited 2021 Q3 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceuticals (@TevaUSA) / Twitter
